Back to Search
GABRIEL NOEL, PHARMD
PHARMD
Pharmacist
NPI: 1467048892Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
033.0120471(VT)
Research & Publications (20)
Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma.
PMID 19203844·Int J Radiat Oncol Biol Phys·2009
8-other
Differential immunological phenotypes are exhibited after scald and flame burns.
PMID 18650781·Shock·2009
7-preclinical
Population pharmacokinetic analysis of ceftobiprole for treatment of complicated skin and skin structure infections.
PMID 19075059·Antimicrob Agents Chemother·2009
8-other
Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole.
PMID 19451287·Antimicrob Agents Chemother·2009
7-preclinical
Pharmacodynamic profiling of ceftobiprole for treatment of complicated skin and skin structure infections.
PMID 19528285·Antimicrob Agents Chemother·2009
8-other
Cytokine-induced epithelial permeability changes are regulated by the activation of the p38 mitogen-activated protein kinase pathway in cultured Caco-2 cells.
PMID 17724435·Shock·2008
8-other
Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion.
PMID 18726885·J Surg Oncol·2008
6-review
A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media.
PMID 18449063·Pediatr Infect Dis J·2008
4-observational
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.
PMID 17954698·Antimicrob Agents Chemother·2008
4-observational
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.
PMID 18225981·Clin Infect Dis·2008
4-observational
Characterization and dynamics of middle ear fluid and nasopharyngeal isolates of Streptococcus pneumoniae from 12 children treated with levofloxacin.
PMID 17999965·Antimicrob Agents Chemother·2008
8-other
Proton therapy in pediatric skull base and cervical canal low-grade bone malignancies.
PMID 18440726·Int J Radiat Oncol Biol Phys·2008
3-trial
Distribution of potassium ion and water permeable channels at perivascular glia in brain and retina of the Large(myd) mouse.
PMID 17803675·J Neurochem·2007
7-preclinical
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders.
PMID 17901792·Pediatr Infect Dis J·2007
3-trial
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
PMID 17901791·Pediatr Infect Dis J·2007
4-observational
A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.
PMID 17889276·Int J Radiat Oncol Biol Phys·2007
4-observational
Stress and prolactin effects on bone marrow myeloid cells, serum chemokine and serum glucocorticoid levels in mice.
PMID 18287810·Neuroimmunomodulation·2007
7-preclinical
Clinical profile of ceftobiprole, a novel beta-lactam antibiotic.
PMID 17488373·Clin Microbiol Infect·2007
6-review
Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects.
PMID 17387149·Antimicrob Agents Chemother·2007
4-observational
Anti-MRSA beta-lactams in development, with a focus on ceftobiprole: the first anti-MRSA beta-lactam to demonstrate clinical efficacy.
PMID 17371191·Expert Opin Investig Drugs·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 205 NORTH ST
BENNINGTON, VT 05201 - Phone
- (802) 442-5602
Quick Facts
- NPI
- 1467048892
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile